(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
![BK9AH5 | 1034305-21-9 | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate](https://qncdn.chemcd.cn/alchemypharm/AP10807.png "BK9AH5 | 1034305-21-9 | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate")
Catalog No.: BK9AH5
CAS.RN：1034305-21-9
Molecular Formula: C29H29FO9S
Molecular Weight: 572.60 g/mol
Purity: NLT 98%
Intermediates of Ipragliflozin
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA9X05 | Ipragliflozin API | 761423-87-4 |
| BK7Q8G | D-Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, δ-lactone | 32384-65-9 |
| BK9AH5 | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | 1034305-21-9 |
| BK77NU | Benzo[b]thiophene, 2-[(5-bromo-2-fluorophenyl)methyl]- | 1034305-17-3 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
